recision for Value excels at
demonstrating the value
of medical innovations to
payers, providers, and policy makers, agency leaders
say. According to its executives, Precision
is becoming a global leader in the generation and communication of clinical, economic, and societal value of a particular
medicine, and three acquisitions in 2015
put them further ahead of traditional
communication agencies.

According to agency leaders, Precision
is focused on pharma and life sciences clients that are concerned about the
increasing demands by global decision
makers to demonstrate and communicate the value of medical breakthroughs
to address unmet patient needs and improve outcomes. “Precision’s cohesive set
of core services – led by some of the most
recognized experts in the industry – help
pharma and life science companies create
and communicate the value of their new
treatments and also justify reimbursement for them aligned to the value provided,” executives say.

Precision’s accomplishments over the
past year have been signi;cant,
executives say, claiming that last year, Precision grew a “remarkable” 114 percent.
That performance was driven by organic growth, acquisitions, and new client
wins, resulting in numerous new product
assignments and above-brand business.

Executives say this growth included
workforce expansion to more than 275
employees in 11 locations that include
Boston, New York City, New Jersey, Chicago, London, Los Angeles, San Francisco, and Vancouver. “Last year was one of
the best in the history of the company,”
agency leaders say.

Last year Precision for Value secured
24 new clients, and now has a roster of
94 clients worldwide, according to executives. “By continuing to fuse thought
leadership, health economics, analytics,
and strategic payer marketing services,
we’re working with our clients to formulate strategy, create compelling evidence,
demonstrate outcomes, and optimize
commercial success, and patients are
benefiting from new choices that can be
accessed and afforded,” executives say.

Precision for Value made three significant acquisitions in 2015: Precision
Health Economics (PHE), which was
acquired in April; LehmanMillet, now
Precision Effect, acquired in May; and in
November, Redwood Outcomes.

PHE applies academic rigor to themost challenging problems in healthcareto influence policy and outcomes, accord-ing to executives. “As part of Precisionfor Value, this academic research can belinked to tailored commercial approach-es to demonstrate the value of innovativemedicines,” executives say. With PHE,Precision expands its presence in Los An-geles, Boston, and Austin.LehmanMillet Group, now PrecisionEffect, is a highly regarded communica-tions agency well known for working withinnovative health companies who arechanging the standard of care, executivessay. They add that Precision Effect willoperate alongside Precision for Value toensure real value is delivered to all stake-holders, including physicians, providers,and patients. “This addition expands Pre-cision’s capabilities and ability to supportproducts at different stages of the prod-uct life cycle,” executives say.Redwood Outcomes, a Vancouver- andSan Francisco-based research group,serves pharmaceutical and biotechnologycompanies and applies the science of ev-idence generation, synthesis, and model-ing to optimize healthcare decision mak-ing, according to Precision. “This teamof experts helps clients determine whichtherapies and treatments are most likelyto benefit patients, especially in the con-text of ever more challenging evidentiarystandards,” executives say. “RedwoodOutcomes is also a leader in a rapidlygrowing niche of health economics thatEuropean governments view as instru-mental to making healthcare coveragedecisions. Redwood will be integratedinto Precision Health Economics.”During 2015, Precision significantlyexpanded its global pricing and marketaccess-related services by hiring newtalent and increasing its offerings. Preci-sion’s Global Pricing and Market Access(GPMA) offering develops robust andactionable value-based pricing strate-gies that articulate the necessary clinicalevidence to substantiate value to globalproviders, payers, and regulators, ac-cording to executives.“Precision for Value is building on itssuccess and acquiring companies thatallow us to see and predict trends inthe marketplace before they happen,”says Dan Renick, president, Precisionfor Value. “By combining these expertsand proficiencies with our internal teamof former payers, we believe we have anunmatched ability to help pharma andlife sciences companies innovate, devel-op, and commercialize next-generationmedical products.”According to its leaders, Precision forValue provides a uniquely focused set ofservices that integrate the generation andcommunication of the evidence neces-sary to establish value, optimize access,and drive demand. These include man-aged market access strategies, advancedpayer analytics, health economics, andmarketing communications.The company’s services include prod-uct strategies and evidence planning;marketing communications strategy forboth payers and provider groups; pub-lic policy influence through insightful,issue-driven research; health economicsand outcomes research; pricing and con-tracting; and data-driven message seg-mentation and delivery.Executives say Precision for Valuemaintains its leading edge through theinsights of subject matter experts andrecognized thought leaders with ex-tensive real-world market experienceacross multiple disciplines, includingleadership positions at health plans,pharmacy benefit managers, integrateddelivery systems, life science consultan-cies, government agencies, academia,and pharmaceutical manufacturers. Theteam leverages its unique combinationof experiences to inform the creation ofinnovative strategies and communica-tion plans that address challenges withpayer access for both newly launchedand existing products.The company’s leadership is widely ac-knowledged for its expertise in managedmarkets and promotional effectiveness.Precision for Value is led by Renick; Car-los Delucca, executive VP and managingpartner; Kelly Wilder, executive VP andmanaging partner; Bruce Leavitt, execu-tive VP and managing partner, businessanalytics and promotional effectiveness;and Larry Blandford, executive VP andmanaging partner.“Precision for Value is an industryleader in identifying and demonstratingthe value of medical innovations to pay-ers, providers, policy makers, and pa-tients,” executives say. “Their unmatchedexpertise in supporting life sciences andpharmaceutical clients in their mission tooptimize market access and improve carefor patients around the world is makingPrecision for Value a preferred strategicpartner in the industry today.”The Precision for Value Boston team part-nered with Cradles to Crayons to supportthe annual “Gear Up for Winter” initia-tive. The team helped 130 children byassembling care packages that were indi-vidually selected for each child. Cradles toCrayons is a charity whose vision is that“one day every child will have the essen-tials they need…to stay safe, warm, readyto learn, and valued,” executives sayPrecision’s Gladstone, N.J., office helda Veteran’s Day event to support and do-nate to local veterans. Precision workedwith the Warrior Canine Connection,enabling employees to donate to thisorganization, which enlists recoveringsoldiers in a mission of learning to trainservice dogs for their fellow veterans.The N.J. staff also participated in a char-ity team building event where they builtbikes for children from the Boys and GirlsClub. The bikes were presented in personto the kids from the clubs and their men-tors along with backpacks filled with ad-ditional educational items for each child.Precision Health Economics continuedits “PHE Cares” Initiative, launched in2012, by collecting school supplies andbackpacks for local kids as they head-ed back to school. During the holidays,PHE also participated in the Los Ange-les County DPSS “Adopt-a-Family” pro-gram, donating toys, clothes, bedding,toiletries, and household goods for fivelocal families in need. medadnewsPPrecision for Value